VICTORIA – VICTORIA, British Columbia (AP) _ Aurinia Pharmaceuticals Inc. (AUPH) on Friday reported a loss of $4.1 million in its fourth quarter.
On a per-share basis, the Victoria, British Columbia-based company said it had a loss of 13 cents. Losses, adjusted for non-recurring gains, were 16 cents per share.
The biotechnology company posted revenue of $57,000 in the period.
For the year, the company reported that its loss widened to $18.6 million, or 58 cents per share. Revenue was reported as $235,000.
In the final minutes of trading on Friday, the company’s shares hit $3.04. A year ago, they were trading at $4.80.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AUPH at http://www.zacks.com/ap/AUPH
_____
Keywords: Aurinia Pharmaceuticals, Earnings Report
